Drugs interactions for Cinryze®

  • 0 Major drug interactions
  • 15 Moderate drug interactions (including ingredients like Desogestrel, Dienogest, Drospirenone)
  • 0 Minor drug interactions
15 interactions for Cinryze®
A therapy excluded from this list of known interactions does not necessarily mean that no interactions exist between that therapy and and Cinryze®.
Desogestrel
The risk or severity of thromboembolism can be increased when Desogestrel is combined with Human C1-esterase inhibitor.
Dienogest
The risk or severity of thromboembolism can be increased when Dienogest is combined with Human C1-esterase inhibitor.
Drospirenone
The risk or severity of thromboembolism can be increased when Drospirenone is combined with Human C1-esterase inhibitor.
Ethynodiol diacetate
The risk or severity of thromboembolism can be increased when Ethynodiol diacetate is combined with Human C1-esterase inhibitor.
Etonogestrel
The risk or severity of thromboembolism can be increased when Etonogestrel is combined with Human C1-esterase inhibitor.
Gestodene
The risk or severity of thromboembolism can be increased when Gestodene is combined with Human C1-esterase inhibitor.
Hydroxyprogesterone caproate
The risk or severity of thromboembolism can be increased when Hydroxyprogesterone caproate is combined with Human C1-esterase inhibitor.
Levonorgestrel
The risk or severity of thromboembolism can be increased when Levonorgestrel is combined with Human C1-esterase inhibitor.
Medroxyprogesterone acetate
The risk or severity of thromboembolism can be increased when Medroxyprogesterone acetate is combined with Human C1-esterase inhibitor.
Megestrol acetate
The risk or severity of thromboembolism can be increased when Megestrol acetate is combined with Human C1-esterase inhibitor.
Norelgestromin
The risk or severity of thromboembolism can be increased when Norelgestromin is combined with Human C1-esterase inhibitor.
Norethisterone
The risk or severity of thromboembolism can be increased when Norethisterone is combined with Human C1-esterase inhibitor.
Norgestimate
The risk or severity of thromboembolism can be increased when Norgestimate is combined with Human C1-esterase inhibitor.
Norgestrel
The risk or severity of thromboembolism can be increased when Norgestrel is combined with Human C1-esterase inhibitor.
Progesterone
The risk or severity of thromboembolism can be increased when Progesterone is combined with Human C1-esterase inhibitor.